Follow
kumar sanjiv
kumar sanjiv
SciLifelab, Karolinska Institutet, Stockholm, Sweden
Verified email at scilifelab.se
Title
Cited by
Cited by
Year
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
H Gad, T Koolmeister, AS Jemth, S Eshtad, SA Jacques, CE Ström, ...
Nature 508 (7495), 215-221, 2014
5312014
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
KVM Huber, E Salah, B Radic, M Gridling, JM Elkins, A Stukalov, ...
Nature 508 (7495), 222-227, 2014
4352014
Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer
M Asim, F Tarish, HI Zecchini, K Sanjiv, E Gelali, CE Massie, A Baridi, ...
Nature communications 8 (1), 374, 2017
2492017
Small-molecule inhibitor of OGG1 suppresses proinflammatory gene expression and inflammation
T Visnes, A Cázares-Körner, W Hao, O Wallner, G Masuyer, O Loseva, ...
Science 362 (6416), 834-839, 2018
1912018
Cancer-specific synthetic lethality between ATR and CHK1 kinase activities
K Sanjiv, A Hagenkort, JM Calderón-Montańo, T Koolmeister, PM Reaper, ...
Cell reports 14 (2), 298-309, 2016
1482016
Validation and development of MTH1 inhibitors for treatment of cancer
UW Berglund, K Sanjiv, H Gad, C Kalderen, T Koolmeister, T Pham, ...
Annals of oncology 27 (12), 2275-2283, 2016
1392016
Targeting DNA repair, DNA metabolism and replication stress as anti‐cancer strategies
JC Puigvert, K Sanjiv, T Helleday
The FEBS journal 283 (2), 232-245, 2016
1382016
Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies
N Herold, SG Rudd, L Ljungblad, K Sanjiv, IH Myrberg, CBJ Paulin, ...
Nature medicine 23 (2), 256-263, 2017
1212017
Development of chitosan oligosaccharide-modified gold nanorods for in vivo targeted delivery and noninvasive imaging by NIR irradiation
S Charan, K Sanjiv, N Singh, FC Chien, YF Chen, NN Nergui, SH Huang, ...
Bioconjugate chemistry 23 (11), 2173-2182, 2012
792012
SAMHD1 protects cancer cells from various nucleoside-based antimetabolites
N Herold, SG Rudd, K Sanjiv, J Kutzner, J Bladh, CBJ Paulin, T Helleday, ...
Cell Cycle 16 (11), 1029-1038, 2017
662017
Global survey of the immunomodulatory potential of common drugs
GI Vladimer, B Snijder, N Krall, JW Bigenzahn, KVM Huber, CH Lardeau, ...
Nature chemical biology 13 (6), 681-690, 2017
602017
Synthesis of tunable and multifunctional Ni-doped near-infrared QDs for cancer cell targeting and cellular sorting
N Singh, S Charan, K Sanjiv, SH Huang, YC Hsiao, CW Kuo, FC Chien, ...
Bioconjugate chemistry 23 (3), 421-430, 2012
582012
The spliceosome U2 snRNP factors promote genome stability through distinct mechanisms; transcription of repair factors and R-loop processing
M Tanikawa, K Sanjiv, T Helleday, P Herr, O Mortusewicz
Oncogenesis 5 (12), e280-e280, 2016
532016
With me or against me: Tumor suppressor and drug resistance activities of SAMHD1
N Herold, SG Rudd, K Sanjiv, J Kutzner, IH Myrberg, CBJ Paulin, ...
Experimental hematology 52, 32-39, 2017
482017
Epidemiological typing of Staphylococcus aureus by DNA restriction fragment length polymorphism of coa gene
K Sanjiv, AK Kataria, R Sharma, G Singh
Veterinarski arhiv 78 (1), 31-38, 2008
472008
Ribonucleotide reductase inhibitors suppress SAMHD 1 ara‐CTP ase activity enhancing cytarabine efficacy
SG Rudd, N Tsesmetzis, K Sanjiv, CBJ Paulin, L Sandhow, J Kutzner, ...
EMBO molecular medicine 12 (3), e10419, 2020
412020
Targeting OGG1 arrests cancer cell proliferation by inducing replication stress
T Visnes, C Benítez-Buelga, A Cázares-Körner, K Sanjiv, BMF Hanna, ...
Nucleic acids research 48 (21), 12234-12251, 2020
392020
Glioblastoma and glioblastoma stem cells are dependent on functional MTH1
L Pudelko, P Rouhi, K Sanjiv, H Gad, C Kalderén, A Höglund, M Squatrito, ...
Oncotarget 8 (49), 84671, 2017
352017
Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity
PC Lee, HJ Lee, R Kakadiya, K Sanjiv, TL Su, TC Lee
Oncogene 32 (9), 1144-1154, 2013
322013
The novel DNA alkylating agent BO‐1090 suppresses the growth of human oral cavity cancer in xenografted and orthotopic mouse models
K Sanjiv, TL Su, S Suman, R Kakadiya, TC Lai, HY Wang, M Hsiao, ...
International journal of cancer 130 (6), 1440-1450, 2012
302012
The system can't perform the operation now. Try again later.
Articles 1–20